Download PDF
Thromb Haemost 1995; 73(02): 231-238
DOI: 10.1055/s-0038-1653756
Original Article
Coagulation
Schattauer GmbH Stuttgart

Internalization and Degradation of Recombinant Human Coagulation Factor VIIa by the Human Hepatoma Cell Line HuH7

Glenn T G Chang
The Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA
,
Walter Kisiel
The Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA
› Author Affiliations
Further Information

Publication History

Received 08 June 1994

Accepted after resubmission 18 October 1994

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Previous studies demonstrated that several normal and transformed cultured human cell lines specifically bind human coagulation factors VII and VIIa via tissue factor. In the present study, we show that 125I- radiolabeled recombinant human factor VIIa (125I-rFVIIa) binds to a human hepatoma cell line (HuH7). In the presence of rabbit polyclonal anti-human tissue factor apoprotein IgG, binding of 125I-rFVIIa to the HuH7 cells was decreased ∼60%, suggesting the presence of tissue factor-independent binding sites for 125I-rFVIIa on these cells. The binding isotherm of 125I-rFVIIa for the HuH7 cells in the presence of anti-tissue factor IgG exhibited a hyperbolic profile and was time-, temperature- and calcium-dependent. Furthermore, binding at 4° C was specific, dose-dependent and saturable. Scatchard analysis of the binding data demonstrated a single class of binding sites with a dissociation constant (Kd) of 3.2 nM and 27,000 binding sites per cell. At 4° C, 125I-rFVIIa bound to, and eluted from, the cell was indistinguishable from offered 125I-rFVIIa as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by autoradiography.

The molecular properties of the tissue factor-independent binding protein were studied by using the cleavable cross-linking agent 3, 3’- dithiobis(sulfosuccinimidylpropionate). A cross-linking product of 125I-rFVIIa and a cell surface protein with an apparent Mr ∼100,000 was observed. The cross-linking reaction was strongly inhibited by a 100-fold molar excess of unlabeled rFVIIa, but not by rabbit polyclonal anti-human tissue factor apoprotein IgG, indicating that cross-linking does not involve the extracellular domain of tissue factor.

After binding, internalization of 125I-rFVIIa by the HuH7 cells was observed at 37° C in the presence of rabbit polyclonal anti-human tissue factor apoprotein IgG. Internalization of 125I-rFVIIa proceeds at a rate of 0.4 fmol 125I-rFVIIa/min/106 cells, reaching a steady state after 2 h. Following binding and internalization, 125I-rFVIIa reappeared in the culture medium within 30 min, at approximately the same rate as internalized 125I-rFVIIa. This 125I-rFVIIa probably represents degradation of 125I-rFVIIa into small peptides, since it could not be precipitated by rabbit polyclonal affinity-purified anti-FVII IgG or by trichloroacetic acid. Chloroquine treatment of the HuH7 cells inhibited the degradation of 125I-rFVIIa, suggesting that degradation presumably occurs via a lysosomal-dependent pathway. These studies demonstrate that the liver may play an important role in the clearance mechanism(s) of FVIIa.

 

  • References

  • 1 Davie EW S, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry 1991; 30: 10363-10370
    CrossrefPubMedGoogle Scholar
  • 2 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodburgy RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-2416
    CrossrefPubMedGoogle Scholar
  • 3 Broze Jr GJ, Majerus PW. Purification and properties of human coagulation factor VII. J Biol Chem 1980; 255: 1242-1247
    PubMedGoogle Scholar
  • 4 Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53: 505-518
    CrossrefPubMedGoogle Scholar
  • 5 Fair DS. Quantification of factor VII in the plasma of normal and warfarin- treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
    PubMedGoogle Scholar
  • 6 Kisiel W, Fujikawa K, Davie EW. Activation of bovine factor VII (proconvertin) by factor Xlla (activated Hageman factor). Biochemistry 1977; 16: 4189-4194
    CrossrefPubMedGoogle Scholar
  • 7 Broze Jr GJ, Majerus PW. Human factor VII. Methods Enzymol 1980; 80: 228-237
    PubMedGoogle Scholar
  • 8 Masys DR, Bajaj SP, Rapaport SI. Activation of human factor VII by activated factors IX and X. Blood 1982; 60: 1143-1150
    PubMedGoogle Scholar
  • 9 Wildgoose P, Kisiel W. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells. Blood 1989; 73: 1888-1895
    PubMedGoogle Scholar
  • 10 Pedersen AH, Lund-Hansen T, Bisgaard-Frantzen H, Olsen F, Pedersen LC. Autoactivation of human recombinant coagulation factor VII. Biochemistry 1989; 28: 9331-9336
    CrossrefPubMedGoogle Scholar
  • 11 Broze Jr GJ. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70: 526
    CrossrefPubMedGoogle Scholar
  • 12 Rodgers GM, Greenberg CS, Shuman MA. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61: 1155-1162
    PubMedGoogle Scholar
  • 13 Rodgers GM, Broze Jr GJ, Shuman MA. The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood 1984; 63: 434-438
    PubMedGoogle Scholar
  • 14 Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation. Association of factor Vila with a cell line expressing tissue factor J Biol Chem 1987; 262: 9503-9508
    PubMedGoogle Scholar
  • 15 Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 11692-11698
    PubMedGoogle Scholar
  • 16 Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation J Biol Chem 1989; 264: 9980-9988
    PubMedGoogle Scholar
  • 17 Reuning U, Preissner KT, Miiller-Berghaus G. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa. Thromb Haemost 1993; 69: 197-204
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Nemerson Y. Tissue factor and haemostasis. Blood 1988; 71: 1-8
    PubMedGoogle Scholar
  • 19 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Rapaport SI, Rao LV M. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121
    CrossrefPubMedGoogle Scholar
  • 21 Hasselback R, Hjort PF. Effect of heparin on in vivo turnover of clotting factors. J Appl Physiol 1960; 15: 945-948
    CrossrefPubMedGoogle Scholar
  • 22 Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurements of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992; 80: 25-28
    PubMedGoogle Scholar
  • 23 Morrisey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744
    PubMedGoogle Scholar
  • 24 Seligsohn U, Kasper CK, Østerud B, Rapaport SI. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood 1979; 53: 828-837
    PubMedGoogle Scholar
  • 25 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR S, Haines AP, Stirling Y, Imesion JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 537-553
    PubMedGoogle Scholar
  • 26 Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Arteriosclerosis 1986; 60: 269-277
    CrossrefPubMedGoogle Scholar
  • 27 Dalaker K, Hjermann I, Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol 1985; 61: 315-322
    CrossrefPubMedGoogle Scholar
  • 28 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1989; 14: 941-946
    CrossrefPubMedGoogle Scholar
  • 29 Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII by two techniques: evidence for increased conversion of VII to α VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-258
    CrossrefPubMedGoogle Scholar
  • 30 Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirshahi M, de Gennes JL, Caen JP. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study. Haemostasis 1989; 19: 83-90
    PubMedGoogle Scholar
  • 31 Skartlien AH, Lynberg-Beckmann S, Holme I, Hjermann I, Prydz H. Effect of alteration in triglyceride levels on factor VII-phospholipids complexes in plasma. Arteriosclerosis 1989; 9: 798-801
    CrossrefPubMedGoogle Scholar
  • 32 Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-944
    CrossrefPubMedGoogle Scholar
  • 33 Mitropoulos KA, Miller GJ, Reeves BE A, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. Atherosclerosis 1989; 76: 203-208
    CrossrefPubMedGoogle Scholar
  • 34 Spaeth TH, Kropatkin M. Effect of intravenous blood thromboplastin inter. mediates on clotting in rats Amer J Physiol 1958; 195: 77-80
    PubMedGoogle Scholar
  • 35 Deykin D, Chun R, Lopez A, Silversmity P. The role of the liver in serum induced hypercoagulability. J Clin Invest 1966; 45: 256-263
    CrossrefPubMedGoogle Scholar
  • 36 Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 3858-3863
    PubMedGoogle Scholar
  • 37 Kondo S, Kisiel W. Evidence that plasma lipoproteins inhibit the factor VII-tissue factor complex by a different mechanism than extrinsic pathway inhibitor. Blood 1987; 70: 1947-1954
    PubMedGoogle Scholar
  • 38 Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIIa from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-7793
    CrossrefPubMedGoogle Scholar
  • 39 Fraker PJ, Speck JR JC. Protein and cell membrane iodinations with a sparingly soluble chloramide, l, 3,4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-857
    CrossrefPubMedGoogle Scholar
  • 40 Nawroth PP, McCarthy D, Kisiel W, Handley D, Stem DM. Cellular processing of bovine factors X and Xa by cultured bovine aortic endothelial cells. J Exp Med 1985; 162: 559-572
    CrossrefPubMedGoogle Scholar
  • 41 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 42 Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-672
    CrossrefPubMedGoogle Scholar
  • 43 Basu SK, Goldstein JL, Brown MS. Characterization of the low density lipoprotein receptor in membranes prepared from human fibriblasts. J Biol Chem 1978; 253: 3852-3856
    PubMedGoogle Scholar
  • 44 Ciechanover A, Schwartz AK, Lodish HF. Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J Cell Biochem 1983; 23: 107-130
    CrossrefPubMedGoogle Scholar
  • 45 Goldstein JL, Anderson RG W, Brown MS. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 1979; 279: 679-685
    CrossrefPubMedGoogle Scholar
  • 46 Thomsen MK, Diness V, Nilsson P, Rasmussen SN, Taylor T, Hedner U. Pharmacokinetics of recombinant factor VIIa in the rat - a comparison of bio-, immuno- and isotope assays. Thromb Haemost 1993; 70: 458-464
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Beeby TL, Chasseaud LF, Taylor T, Thomsen MK. Distribution of the recombinant coagulation factor l25I-rFVIIa in rats. Thromb Haemost 1993; 70: 465-468
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Hoffman M, Monroe DM, Roberts R. Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in Hemophilia. Blood 1994; 83: 38-42
    PubMedGoogle Scholar
  • 49 Neuenschwander PF, Morrisey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function Analysis of a mutant with a selective deficiency in activity J Biol Chem 1992; 267: 14477-14482
    PubMed
  • 50 Waxman E, Ross JB A, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y. Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex. Biochemistry 1992; 31: 3998-4003
    CrossrefPubMedGoogle Scholar
  • 51 Ruf W, Kalnik MW, Lund-Hansen T, Edgington TS. Characterization of factor VII association with tissue factor in solution. J Biol Chem 1991; 266: 15719-15725
    PubMedGoogle Scholar
  • 52 Toomey JR, Smith KJ, Stafford DW. Localization of the human tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-19202
    PubMedGoogle Scholar
  • 53 Clarke BJ, Ofosu FA, Sridhara S, Bona RD, Rickies FR, Blajchman MA. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett 1992; 298: 206-210
    CrossrefPubMedGoogle Scholar
  • 54 Kazama Y, Pastuszyn A, Wildgoose P, Hamamoto T, Kisiel W. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor Vila. J Biol Chem 1993; 268: 16231-16240
    PubMedGoogle Scholar